Literature DB >> 36161376

ASO Author Reflections: Commercialization of Adaptive Cell Therapy for Metastatic Melanoma.

Keshav Kooragayala1, Johanna Lou1, Young Ki Hong2.   

Abstract

Entities:  

Year:  2022        PMID: 36161376     DOI: 10.1245/s10434-022-12588-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  4 in total

1.  Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study.

Authors:  Caroline Robert; Antoni Ribas; Jacob Schachter; Ana Arance; Jean-Jacques Grob; Laurent Mortier; Adil Daud; Matteo S Carlino; Catriona M McNeil; Michal Lotem; James M G Larkin; Paul Lorigan; Bart Neyns; Christian U Blank; Teresa M Petrella; Omid Hamid; Shu-Chih Su; Clemens Krepler; Nageatte Ibrahim; Georgina V Long
Journal:  Lancet Oncol       Date:  2019-07-22       Impact factor: 41.316

Review 2.  Managing Metastatic Melanoma in 2022: A Clinical Review.

Authors:  Benjamin Switzer; Igor Puzanov; Joseph J Skitzki; Lamya Hamad; Marc S Ernstoff
Journal:  JCO Oncol Pract       Date:  2022-02-08

3.  Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma.

Authors:  Samantha J Seitter; Richard M Sherry; James C Yang; Paul F Robbins; Mackenzie L Shindorf; Amy R Copeland; Christine T McGowan; Monica Epstein; Thomas E Shelton; Michelle M Langhan; Zulmarie Franco; David N Danforth; Donald E White; Steven A Rosenberg; Stephanie L Goff
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531

4.  Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Authors:  Jedd D Wolchok; Vanna Chiarion-Sileni; Rene Gonzalez; Piotr Rutkowski; Jean-Jacques Grob; C Lance Cowey; Christopher D Lao; John Wagstaff; Dirk Schadendorf; Pier F Ferrucci; Michael Smylie; Reinhard Dummer; Andrew Hill; David Hogg; John Haanen; Matteo S Carlino; Oliver Bechter; Michele Maio; Ivan Marquez-Rodas; Massimo Guidoboni; Grant McArthur; Celeste Lebbé; Paolo A Ascierto; Georgina V Long; Jonathan Cebon; Jeffrey Sosman; Michael A Postow; Margaret K Callahan; Dana Walker; Linda Rollin; Rafia Bhore; F Stephen Hodi; James Larkin
Journal:  N Engl J Med       Date:  2017-09-11       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.